Kanabo Studying Vaping With CBD And Nicotine Mix To Help Smokers Quit Tobacco And Nicotine
Executive Summary
Kanabo, with headquarters in London and R&D in Tel Aviv, says its CBD and nicotine formula has advanced in the patent process from being recognized in the UK to being considered for recognition in the US and the EU, a step it calls “the last phase before becoming an internationally approved patent.”
You may also be interested in...
Will Novel NRT Interest Heat Up In US With First Clearance For ENDS Under Tobacco Control Act?
Without mentioning NRT space, FDA’s acceptance of one vape device and two replacement nicotine cartridges as tobacco products might reignite interest in proposals for ENDS or other novel products to be approved for smoking cessation claims. To gain clearance as tobacco products, the ENDS were shown to provide a benefit similar to efficacies required for an NRT.
J&J’s Nicorette QuickMist SmartTrack – Getting Inside One Of 2020’s Biggest UK Launches
HBW Insight speaks to Johnson & Johnson's Bill Twomey and Sven Sjovall about how one of the biggest OTC launches of 2020 – Nicorette QuickMist SmartTrack – uses behavioral science techniques to help motivate consumers to quit smoking and overcame COVID-related supply chain difficulties to launch a much-needed digital smoking cessation aid in the middle of a pandemic.
GSK’s Proposal For Mouth Spray Nicorette Delayed By FDA Questions On Label
Glaxo plans to make changes FDA requested in Complete Response letter sent on 18 October, the agency’s deadline for acting on NDA for an oral spray that delivers 1 mg per spray of aqueous buffered nicotine solution for oromucosal use.